Recommendations for the clinical and laboratory diagnosis of VITT against COVID‐19: Communication from the ISTH SSC Subcommittee on Platelet Immunology

Vaccine administration is under way worldwide to combat the current COVID‐19 pandemic. The newly developed vaccines are highly effective with minimal adverse effects. Recently, the AstraZeneca ChadOx1 nCov‐19 vaccine has raised public alarm with concerns regarding the rare, but serious, development...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thromb Haemost
Autors principals: Nazy, Ishac, Sachs, Ulrich J., Arnold, Donald M., McKenzie, Steven E., Choi, Phil, Althaus, Karina, Ahlen, Maria Therese, Sharma, Ruchika, Grace, Rachael F., Bakchoul, Tamam
Format: Artigo
Idioma:Inglês
Publicat: International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2021
Matèries:
Recommendations and Guidelines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250233/
https://ncbi.nlm.nih.gov/pubmed/34018298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15341
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars